Format

Send to

Choose Destination
Infection. 2011 Jun;39(3):225-30. doi: 10.1007/s15010-011-0114-8. Epub 2011 May 3.

Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure.

Author information

1
Medical ICU, Hôpital Saint-Louis, Assistance-Publique Hôpitaux de Paris, 1 avenue Claude Vellefaux, Paris, France.

Abstract

PURPOSE:

Human herpesvirus 6 (HHV6) is an emerging cause of interstitial pneumonia in immunocompromised hosts. However, the clinical significance of a positive PCR test for HHV6 in respiratory samples from patients with hematological malignancies remains unclear.

METHODS:

We retrospectively studied the features and outcomes of 29 critically ill hematology patients with acute respiratory failure and lung pulmonary infiltrates visible on a chest radiograph, who tested positive for a qualitative PCR for HHV6 in bronchoalveolar lavage fluid.

RESULTS:

Of the 29 patients, 18 (62%) were stem cell transplant recipients and 11 (38%) had received chemotherapy. All patients had a fever. Clinical manifestations consistent with extra-pulmonary HHV6 disease were noted in 17 (59%) patients. One or more co-pathogens were found in 25 (86%) patients. The four remaining patients diagnosed with HHV6 pneumonia and subsequently recovered with foscarnet therapy. Antiviral therapy was also given to seven patients with co-infections, of whom two ultimately died.

CONCLUSIONS:

In most cases, HHV6 recovered from BAL fluid is a co-pathogen whose clinical relevance remains undetermined. However, in some cases, HHV6 is the only pathogen, along with disseminated systemic viral disease, and the patient is likely to benefit from foscarnet therapy.

PMID:
21538037
DOI:
10.1007/s15010-011-0114-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center